Omron (OTCMKTS:OMRNY – Get Free Report) posted its quarterly earnings data on Wednesday. The company reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.09 by $0.36, Zacks reports. Omron had a net margin of 3.66% and a return on equity of 2.90%. Omron updated its FY 2026 guidance to 1.292-1.292 EPS.
Omron Stock Up 17.2%
Shares of OMRNY traded up $6.14 during mid-day trading on Wednesday, hitting $41.77. The company’s stock had a trading volume of 23,294 shares, compared to its average volume of 54,384. The company has a current ratio of 1.83, a quick ratio of 1.41 and a debt-to-equity ratio of 0.08. The company’s 50-day moving average is $35.23 and its 200-day moving average is $32.39. Omron has a 52-week low of $23.23 and a 52-week high of $42.30. The firm has a market capitalization of $8.21 billion, a price-to-earnings ratio of 43.97, a PEG ratio of 0.41 and a beta of 1.14.
Wall Street Analysts Forecast Growth
A number of brokerages recently issued reports on OMRNY. Jefferies Financial Group lowered Omron from a “buy” rating to a “hold” rating in a research note on Tuesday, June 16th. Zacks Research downgraded Omron from a “hold” rating to a “strong sell” rating in a research report on Thursday, June 11th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Reduce”.
About Omron
Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.
Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.
Featured Stories
- Five stocks we like better than Omron
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
- AMD’s Post-Earnings Drop May Be the Opportunity Investors Wanted
- 3 Stocks That Prove the AI Trade Isn’t Over, It Moved
- The FTC Is Suing Hims & Hers Health—Here’s Why Investors Shouldn’t Panic
Receive News & Ratings for Omron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omron and related companies with MarketBeat.com's FREE daily email newsletter.
